Randomized Double Blind Trial (AVERROES):Sub-Investigator, Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or are Unsuitable for Vitamin K Antagoinst Treatment, Bristol-Myers Squibb, 12/07 – pre

Date: August 20, 2012|Source: No Source